Ovarian Cancer Trial, Recruiting NCT06129968 Sponsor: Professor Sudha Sundar Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT06129968
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman who has visited your GP or primary care doctor with possible symptoms of ovarian cancer and has had a CA125 blood test (a test that looks for a specific marker in the blood that can be linked to ovarian cancer) as part of your normal care.

Who may not be able to join:

  • You are visiting your GP or primary care doctor but do not have any possible symptoms of ovarian cancer.
  • You are a woman with symptoms that could be linked to ovarian cancer but have not been given a CA125 blood test for ovarian cancer.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sudha Sundar, University of Birmingham/Sandwell and West Birmingham NHS Trust

Phone: +441214144477

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Professor Sudha Sundar
Registry
ClinicalTrials.gov
Start date
23 January 2024
Est. completion
31 July 2025

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Sensitivity of ROMA versus CA125 in early stage ovarian cancer; Specificity of ROMA versus CA125 in early stage ovarian cancer

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov